Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Alpha Genomix and Rx30 Partner to Provide Personalized Medication Therapy

Posted on: 30 Sep 16

Rx30 is announcing a first to market, actionable pharmacogenetic platform through Alpha Genomix Laboratoriesthat will allow the pharmacist and physician to work collaboratively towards a true personalized medicine approach within their communities. We have established an exclusive agreement with Alpha Genomix Laboratories, a leader in the field of precision medicine, to integrate an actionable, real-time approach to pharmacogenetics specifically for the independent pharmacist. Pharmacogenetics can be the key differentiator in a pharmacies medication management, MTM, and overall patient care programs. Our “myRightMeds” program will help pharmacists select only those patients truly needing the testing, and then integrate patient selection, reporting and future guidance into their Rx30 system.

“We are thrilled to empower Rx30 pharmacists in providing their patient population with a personalized medication treatment plan. By integrating industry leading genetic testing protocols with the most widely utilized pharmacy management software, we now have the capabilities to eliminate a significant amount of adverse events, trial and error, and waste within our country’s healthcare system. This is also an exciting opportunity for pharmacists to pinpoint effective patient care, differentiate in their quality of care, and be a shining example of leadership in implementing advanced programs for improved patient outcomes in this new era of Pay for Performance contracting. We’re committed to help integrate Alpha Genomix exclusively for Rx30 pharmacies and their patients," stated Steve Wubker, President and Chief Executive Officer of Rx30.

“Alpha Genomix is proud to partner with RX30, the Nation’s leading pharmacy management software company, to deliver actionable pharmacogenetic testing to clinicians. For years, experts have predicted that PGT would become standard of care in helping to reduce adverse side effects, trial and error, and waste within our healthcare system. Now we have all the pieces in place to offer a seamless collaboration that unifies the laboratory, the physicians, and pharmacist under a single technological platform to help ensure that patients are prescribed the right medication at the right dose," stated Dr. Hani El Shawa, Chief Executive Officer of Alpha Genomix Laboratories.

About Rx30

Rx30 is a total Pharmacy Management Software application that truly acts as the hub for all pharmacy management activities, including prescription dispensing, fully automated refills and reminders, workflow management, medication therapy management, STAR ratings, adherence management, medication synchronization, document management, smart phone/web refills, e-prescribing, POS, outbound customer communication, IVR integration, business reporting, label printing and a myriad of value added processes and interfaces that assist in streamlining pharmacy management activities and driving profit. For more information visit

About Alpha Genomix Laboratory

Alpha Genomix Laboratory is a CLIA-certified Molecular Diagnostics Laboratory performing clinical genetic testing. Our high complexity laboratory offers the complete spectrum of diagnostic services and delivers critical patient testing to pharmacists, and physicians nationwide. Our state of the art laboratory along with proven pharmacogenetic testing methodology improves prediction of the best medication for patients, by collecting and integrating diverse data & information on individual’s genetics basis. For more information visit

View source version on

Business Wire

Last updated on: 30/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.